Previous 10 | Next 10 |
home / stock / bmymp / bmymp news
This weekly article series provides a summary of dividend changes. A summary table presents relevant data and key statistics of dividend increases. We highlight one of the stocks and present performance, valuation, and earnings charts. For further details see: Dividend I...
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend Champion, Contender, An...
Pharma/biotech is the most attractive subsector. The most overvalued one is life science tools. IXJ: an alternative to XLV. 10 stocks cheaper than their peers in December. For further details see: IXJ: Healthcare Dashboard For December
Halvorsen's 13F portfolio value increased from $32.98B to $36.04B this quarter. The number of positions increased from 88 to 96. Viking Global added McDonald’s and increased General Electric, Humana, Brookfield Asset Management, and Parker Hannifin while dropping Aon plc during...
Dividends are the foundation of our goal to reach financial freedom. We continuously invest in dividend growth stocks to grow our passive income. If the goal is to produce a passive income stream that will one day cover our expenses, making sure that income stream grows is critical. ...
Bristol-Myers Squibb has underperformed through 2021. However, the company is continuing to move forward on its targets. The company is working hard to replace Revlimid and Eliquis, but both will see revenue until the late 2020s. The company's new drug portfolio, supported by a st...
Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analy...
The following slide deck was published by Bristol-Myers Squibb Company in conjunction with this event. For further details see: Bristol-Myers Squibb (BMY) Investor Presentation - Slideshow
Berkshire Hathaway's 13F stock portfolio value remained almost steady at ~$293B. Their largest three holdings are at two-thirds of the entire portfolio. Berkshire Hathaway increased Chevron while reducing Charter Communications, AbbVie, Marsh & McLennan, and Bristol-Myers Squi...
This is a quarterly review of DivGro, my portfolio of dividend growth stocks. I write these reviews to summarize investment decisions and to share portfolio statistics. The article includes charts showing DivGro's composition and how positions contribute to projected annual dividend i...
News, Short Squeeze, Breakout and More Instantly...
Bristol-Myers Squibb $2Pr Company Name:
BMYMP Stock Symbol:
OTCMKTS Market:
Bristol-Myers Squibb $2Pr Website: